Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
University of Pittsburgh
University of Pittsburgh
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Massachusetts General Hospital
Dana-Farber Cancer Institute
University of Birmingham
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Emory University
University of Kansas Medical Center
University of Miami
HealthCare Global Enterprise Ltd.
Infinity Pharmaceuticals, Inc.
Axelar AB
Minneapolis Veterans Affairs Medical Center
Korean South West Oncology Group
Sanofi
Dana-Farber Cancer Institute